Concepedia

Assaf Moore

AM

21

Publications

751

Citations

15

H-Index

1984

Active since

Affiliations

Rabin Medical Center(Current)

Tel Aviv University

Rambam Health Care Campus

Hebrew University of Jerusalem

Technion – Israel Institute of Technology

Assaf Moore is an author at Rabin Medical Center specializing in medicine, oncology, and lung cancer.

ORCID

Top concepts

Publications per year

1984–2022

21

Publications

21

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Raz Mutai, Tamar Barkan, Assaf Moore et al. · The Breast · 2021 · 132 citations · Full text

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Michal Sarfaty, Moshe Leshno, Noa Gordon et al. · European Urology · 2017 · 66 citations

, , +3

Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer

Michal Sarfaty, Peter Hall, Kelvin Chan et al. · European Urology · 2018 · 66 citations · Full text

, , +1

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Assaf Moore, Michal Cohen‐Naftaly, Anna Tobar et al. · Radiation Oncology · 2017 · 65 citations · Full text

Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)

Shira Sherman, Ofer Rotem, Tzippy Shochat et al. · Lung Cancer · 2020 · 47 citations

, , +6

Rows per page

1–5 of 21